A deep learning approach for prediction of Parkinson's disease progression.

Biomed Eng Lett

Department of Computer Science & Engineering, National Institute of Technology Patna, Patna, 800005 India.

Published: May 2020

This paper proposes a deep neural network (DNN) model using the reduced input feature space of Parkinson's telemonitoring dataset to predict Parkinson's disease (PD) progression. PD is a chronic and progressive nervous system disorder that affects body movement. PD is assessed by using the unified Parkinson's disease rating scale (UPDRS). In this paper, firstly, principal component analysis (PCA) is employed to the featured dataset to address the multicollinearity problems in the dataset and to reduce the dimension of input feature space. Then, the reduced input feature space is fed into the proposed DNN model with a tuned parameter norm penalty (L2) and analyses the prediction performance of it in PD progression by predicting Motor and Total-UPDRS score. The model's performance is evaluated by conducting several experiments and the result is compared with the result of previously developed methods on the same dataset. The model's prediction accuracy is measured by fitness parameters, mean absolute error (MAE), root mean squared error (RMSE), and coefficient of determination (R). The MAE, RMSE, and R values are 0.926, 1.422, and 0.970 respectively for motor-UPDRS. These values are 1.334, 2.221, and 0.956 respectively for Total-UPDRS. Both the Motor and Total-UPDRS score is better predicted by the proposed method. This paper shows the usefulness and efficacy of the proposed method for predicting the UPDRS score in PD progression.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235154PMC
http://dx.doi.org/10.1007/s13534-020-00156-7DOI Listing

Publication Analysis

Top Keywords

parkinson's disease
12
input feature
12
feature space
12
disease progression
8
dnn model
8
reduced input
8
motor total-updrs
8
total-updrs score
8
proposed method
8
deep learning
4

Similar Publications

Introduction: Intraoperative microelectrode recording (MER) and intraoperative test stimulation may provide vital information for optimal electrode placement and clinical outcome in movement disorders patients treated with deep brain stimulation (DBS). The aims of this retrospective study were to determine (i) how often the planned (imaging based) placements of electrodes were changed due to MER and intraoperative test stimulation in Parkinson's disease (PD), dystonia and essential tremor (ET) patients; (ii) whether the frequency of repositioning changed over time; (iii) whether patients' age or disease duration (in PD) influenced the frequency of repositioning.

Methods: Data on the planned and the final placement of 141 electrodes in 72 consecutive DBS treated patients (52 PD, 11 dystonia, 9 ET) was collected over the first 8 years of DBS implementation in a single center.

View Article and Find Full Text PDF

Mitochondria and lysosomes are critical for neuronal homeostasis, as highlighted by their dysfunction in various neurological diseases. Recent studies have identified dynamic membrane contact sites between mitochondria and lysosomes, independent of mitophagy and the lysosomal degradation of mitochondrial-derived vesicles (MDVs), allowing bidirectional crosstalk between these cell compartments, the dynamic regulation of organelle networks, and substance exchanges. Emerging evidence suggests that abnormalities in mitochondria-lysosome contact sites (MLCSs) contribute to neurological diseases, including Parkinson's disease, Charcot-Marie-Tooth (CMT) disease, lysosomal storage diseases, and epilepsy.

View Article and Find Full Text PDF

Transcutaneous vagus nerve stimulation for Parkinson's disease: a systematic review and meta-analysis.

Front Aging Neurosci

January 2025

Affiliated Rehabilitation Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.

Background: Transcutaneous vagus nerve stimulation (tVNS) has emerged as a novel noninvasive adjunct therapy for advanced Parkinson's disease (PD), yet no quantitative analysis had been conducted to assess its therapeutic effect.

Objectives: This review aimed to investigate the efficacy of tVNS on motor function, other potential clinical targets and its safety in various treatment conditions.

Methods: We searched six databases for randomized controlled trials (RCTs) that involved treating PD patients with tVNS.

View Article and Find Full Text PDF

The gradually increasing age of the world population implies that the prevalence of neurodegenerative diseases also continues to rise. These diseases are characterized by a progressive loss of cognitive and motor functions. Parkinson's disease, which involves the gradual death of specialized neural tissue, is a striking example of a neurodegenerative process.

View Article and Find Full Text PDF

Brain Age as a New Measure of Disease Stratification in Huntington's Disease.

Mov Disord

January 2025

School of Psychological Sciences and Turner Institute for Brain and Mental Health, Monash University, Melbourne, Victoria, Australia.

Background: Despite advancements in understanding Huntington's disease (HD) over the past two decades, absence of disease-modifying treatments remains a challenge. Accurately characterizing progression states is crucial for developing effective therapeutic interventions. Various factors contribute to this challenge, including the need for precise methods that can account for the complex nature of HD progression.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!